New MS Treatment Shows Promise in Trial
By Amy Norton HealthDay Reporter THURSDAY, Aug. 25, 2022 (HealthDay News) — An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a new clinical trial has found. The drug, called ublituximab, beat a standard oral medication for MS in reducing patients’ relapses — periods of new or … Read more